Disclaimer: The findings of the following analysis are the sole opinions of the writer and should not be considered investment advice Avalanche [AVAX] flipped one-eighty after plunging to its ten-month low in mid-June. The resultant bullish resurgence aided the alt in reclaiming vital support levels. In fixating its spot above the 20/50/200 EMA, the near-term edge […]
